UNIV REGENSBURG KLINIKUM has a total of 36 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are Ruprecht-Karls-Universität Heidelberg , CHIBA PREFECTURE and FOX CHASE CANCER CT.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | Canada | 4 | |
#4 | China | 2 | |
#5 | Germany | 2 | |
#6 | New Zealand | 2 | |
#7 | Australia | 1 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Israel | 1 | |
#10 | Iceland | 1 | |
#11 | Mexico | 1 | |
#12 | Norway | 1 | |
#13 | Ukraine | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Audio-visual technology | |
#5 | Measurement | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Measuring microorganism processes | |
#5 | Implantable devices | |
#6 | Microorganisms | |
#7 | Television | |
#8 | Analysing materials | |
#9 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Holler Ernst | 8 |
#2 | Eissner Guenther | 6 |
#3 | Rehli Michael | 6 |
#4 | Behr Karin | 4 |
#5 | Kuehnel Thomas | 4 |
#6 | Mack Matthias | 3 |
#7 | Michael Rehli | 2 |
#8 | Brandl Katharina | 2 |
#9 | Straub Rainer H | 2 |
#10 | Giegerich Gerhard | 1 |
Publication | Filing date | Title |
---|---|---|
EP2193790A1 | IL-3 Inhibitors in use for treatment of rheumatoid arthritis in an early stage | |
WO2007020075A1 | Use of neuropilin-2 antagonists | |
EP1862555A1 | Means and methods for diagnosing cancer or a corresponding predisposition | |
DE102005000702A1 | Device for central implantation in a tongue body | |
ZA200409558B | Method for the protection of endothelial and epithelial cells during chemotherapy. | |
EP1657257A1 | Recombinant TLR-MD-2 fusion proteins | |
WO2004067751A1 | Use of regulatory sequences for specific, transient expression in neuronal determined cells | |
DE10208406A1 | Variable arm abduction orthosis |